CARLSBAD, Calif.--(BUSINESS WIRE)--April 27, 2006--Invitrogen Corporation (Nasdaq:IVGN - News) today announced results for its first quarter ended March 31, 2006. Revenues for the first quarter were $309.0 million, an increase of 12% over the $277.1 million reported for the first quarter of 2005. Net income for the first quarter was $19.2 million versus $47.1 million for the same quarter in 2005. Earnings per share for the first quarter of 2006 were $0.35 per share, as compared to $0.82 per share reported in the first quarter of 2005. Earnings per share in 2005 included $0.21 per share of income related to currency gains associated with the Dynal acquisition and stock sale gains that did not occur in 2006. Earnings per share in 2006 includes $0.23 per share of higher costs associated with acquisition related amortization and costs, business integration and the implementation of revised Statement of Financial Accounting Standards No. 123, Share-Based Payment (FAS123R).
